{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:11:47Z","timestamp":1792699907349,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ccl.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T20:52:01Z","timestamp":1634849521000},"page":"583-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Raynaud Phenomenon and Other Vasospastic Disorders"],"prefix":"10.1016","volume":"39","author":[{"given":"Ana I.","family":"Casanegra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger F.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2021.06.010_bib1","series-title":"On local asphyxia and symmetrical gangrene of the extremities","author":"Raynaud","year":"1888"},{"key":"10.1016\/j.ccl.2021.06.010_bib2","series-title":"Raynaud\u2019s phenomenon","author":"Coffman","year":"1989"},{"key":"10.1016\/j.ccl.2021.06.010_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","article-title":"International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon","volume":"48-49","author":"Maverakis","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.16.6.1012","article-title":"Raynaud\u2019s disease among women and girls","volume":"16","author":"Gifford","year":"1957","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2021.06.010_bib5","doi-asserted-by":"crossref","first-page":"e006389","DOI":"10.1136\/bmjopen-2014-006389","article-title":"Prevalence, risk factors and associations of primary Raynaud\u2019s phenomenon: systematic review and meta-analysis of observational studies","volume":"5","author":"Garner","year":"2015","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ccl.2021.06.010_bib6","first-page":"879","article-title":"Geographic variation in the prevalence of Raynaud\u2019s phenomenon: a 5 region comparison","volume":"24","author":"Maricq","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"3\u20134","key":"10.1016\/j.ccl.2021.06.010_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/jphysiol.1951.sp004544","article-title":"The loss of heat from the hands and from the fingers immersed in cold water","volume":"112","author":"Greenfield","year":"1951","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"10.1016\/j.ccl.2021.06.010_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/cs0420243","article-title":"Total and nutritional blood flow in the finger","volume":"42","author":"Coffman","year":"1972","journal-title":"Clin Sci"},{"issue":"5","key":"10.1016\/j.ccl.2021.06.010_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJM197107292850505","article-title":"Total and capillary fingertip blood flow in Raynaud\u2019s phenomenon","volume":"285","author":"Coffman","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccl.2021.06.010_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/000331979404500802","article-title":"Primary Raynaud\u2019s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients","volume":"45","author":"Planchon","year":"1994","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00296-012-2484-3","article-title":"Late appearance and exacerbation of primary Raynaud\u2019s phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients","volume":"33","author":"Pavlov-Dolijanovic","year":"2013","journal-title":"Rheumatol Int"},{"issue":"5\u20136","key":"10.1016\/j.ccl.2021.06.010_bib12","first-page":"171","article-title":"The diagnostic value of clinical signs and symptoms in patients with Raynaud\u2019s phenomenon. A cross-sectional study","volume":"37","author":"Wollersheim","year":"1990","journal-title":"Neth J Med"},{"issue":"7","key":"10.1016\/j.ccl.2021.06.010_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/art.1780390717","article-title":"Familial aggregation of primary Raynaud\u2019s disease","volume":"39","author":"Freedman","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1024\/0301-1526\/a000661","article-title":"ESVM guidelines - the diagnosis and management of Raynaud\u2019s phenomenon","volume":"46","author":"Belch","year":"2017","journal-title":"VASA Z Gefasskrankheiten"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3899\/jrheum.091117","article-title":"Thumb involvement in Raynaud\u2019s phenomenon as an indicator of underlying connective tissue disease","volume":"37","author":"Chikura","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"13","key":"10.1016\/j.ccl.2021.06.010_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM198103263041306","article-title":"Is variant angina the coronary manifestation of a generalized vasospastic disorder?","volume":"304","author":"Miller","year":"1981","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.06.010_bib17","doi-asserted-by":"crossref","first-page":"w14506","DOI":"10.4414\/smw.2017.14506","article-title":"Outcomes, rates and predictors of transition of isolated Raynaud\u2019s phenomenon: a systematic review and meta-analysis","volume":"147","author":"Ingegnoli","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib18","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clindermatol.2018.04.004","article-title":"Systemic sclerosis: current concepts of skin and systemic manifestations","volume":"36","author":"Pearson","year":"2018","journal-title":"Clin Dermatol"},{"issue":"11","key":"10.1016\/j.ccl.2021.06.010_bib20","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.ccl.2021.06.010_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"343","author":"Olin","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1358863X9700200404","article-title":"The occurrence of Raynaud\u2019s phenomenon in a general population: the Framingham Study","volume":"2","author":"Brand","year":"1997","journal-title":"Vasc Med Lond Engl"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1979.tb00953.x","article-title":"Vascular symptoms in patients with primary Raynaud\u2019s phenomenon are not exacerbated by propranolol or labetalol","volume":"7","author":"Steiner","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/art.23301","article-title":"Association between treatment with central nervous system stimulants and Raynaud\u2019s syndrome in children: a retrospective case-control study of rheumatology patients","volume":"58","author":"Goldman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.ccl.2021.06.010_bib27","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000641","article-title":"Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association","volume":"139","author":"Campia","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ccl.2021.06.010_bib28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2018-06-846816","article-title":"Acute hyperviscosity: syndromes and management","volume":"132","author":"Gertz","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib29","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86 patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.blre.2006.12.002","article-title":"Cryoglobulinemia","volume":"21","author":"Tedeschi","year":"2007","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.ccl.2021.06.010_bib31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1753193410396636","article-title":"Hand-arm vibration syndrome: a common occupational hazard in industrialized countries","volume":"36","author":"Heaver","year":"2011","journal-title":"J\u00a0Hand Surg Eur Vol"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmv.2012.05.005","article-title":"Le groupe de travail \u00ab Microcirculation \u00bb de la Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine vasculaire. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation Working Group of the French Vascular Medicine Society]","volume":"37","author":"Pistorius","year":"2012","journal-title":"J\u00a0Mal Vasc"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib33","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ccl.2021.06.010_bib34","doi-asserted-by":"crossref","first-page":"104029","DOI":"10.1016\/j.mvr.2020.104029","article-title":"Optimizing finger systolic blood pressure measurements with laser Doppler: validation of the second phalanx site","volume":"131","author":"Blaise","year":"2020","journal-title":"Microvasc Res"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/00365517209080253","article-title":"The measurement of digital systolic blood pressure by strain gauge technique","volume":"29","author":"Nielsen","year":"1972","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"10.1016\/j.ccl.2021.06.010_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.1780280707","article-title":"Angiographic findings in mixed connective tissue disease. Correlation with fingernail capillary photomicroscopy and digital photoplethysmography findings","volume":"28","author":"Peller","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mvr.2010.01.010","article-title":"Correlation of infrared thermography and skin perfusion in Raynaud patients and in healthy controls","volume":"80","author":"Schlager","year":"2010","journal-title":"Microvasc Res"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.40457","article-title":"A\u00a0multicenter study of the validity and reliability of responses to hand cold challenge as measured by laser speckle contrast imaging and thermography: outcome measures for systemic sclerosis-related Raynaud\u2019s phenomenon","volume":"70","author":"Wilkinson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ccl.2021.06.010_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtherbio.2014.09.003","article-title":"Responses in acral and non-acral skin vasomotion and temperature during lowering of ambient temperature","volume":"45","author":"Elstad","year":"2014","journal-title":"J\u00a0Therm Biol"},{"issue":"1\u20132","key":"10.1016\/j.ccl.2021.06.010_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s004200100273","article-title":"Cold-stress tests involving finger skin temperature measurement for evaluation of vascular disorders in hand-arm vibration syndrome: review of the literature","volume":"75","author":"Harada","year":"2002","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"10.1016\/j.ccl.2021.06.010_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1109\/TBME.2013.2243449","article-title":"Relevance of laser Doppler and laser speckle techniques for assessing vascular function: state of the art and future trends","volume":"60","author":"Humeau-Heurtier","year":"2013","journal-title":"IEEE Trans Biomed Eng"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jvs.2013.10.076","article-title":"Digital obstructive arterial disease can be detected by laser Doppler measurements with high sensitivity and specificity","volume":"59","author":"Mahe","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.berh.2013.03.001","article-title":"How to perform and interpret capillaroscopy","volume":"27","author":"Cutolo","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib44","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1152\/japplphysiol.00051.2003","article-title":"Finger dexterity, skin temperature, and blood flow during auxiliary heating in the cold","volume":"95","author":"Brajkovic","year":"2003","journal-title":"J\u00a0Appl Physiol (1985)"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib45","doi-asserted-by":"crossref","first-page":"e024528","DOI":"10.1136\/bmjopen-2018-024528","article-title":"Behaviour change interventions for the management of Raynaud\u2019s phenomenon: a systematic literature review","volume":"8","author":"Daniels","year":"2018","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.ccl.2021.06.010_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/rheumatology\/kep039","article-title":"The efficacy of complementary and alternative medicine in the treatment of Raynaud\u2019s phenomenon: a literature review and meta-analysis","volume":"48","author":"Malenfant","year":"2009","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/rheumatology\/32.6.524-a","article-title":"Amlodipine in the treatment of Raynaud\u2019s phenomenon","volume":"32","author":"La Civita","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib48","article-title":"Calcium channel blockers for primary and secondary Raynaud\u2019s phenomenon [Systematic Review]","volume":"12","author":"Rirash","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib49","first-page":"CD000956","article-title":"Prazosin for Raynaud\u2019s phenomenon in progressive systemic sclerosis","volume":"1998","author":"Harding","year":"1998","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ccl.2021.06.010_bib50","first-page":"215","article-title":"[Raynaud\u2019s phenomenon: effects of terazosin]","volume":"45","author":"Paterna","year":"1997","journal-title":"Minerva Cardioangiol"},{"issue":"12","key":"10.1016\/j.ccl.2021.06.010_bib51","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","article-title":"Losartan therapy for Raynaud\u2019s phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial","volume":"42","author":"Dziadzio","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib52","first-page":"37","article-title":"Treatment of Raynaud\u2019s phenomenon with captopril","volume":"13","author":"Tosi","year":"1987","journal-title":"Drugs Exp Clin Res"},{"issue":"10","key":"10.1016\/j.ccl.2021.06.010_bib53","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud\u2019s phenomenon: systematic review and meta-analysis of randomised trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1016\/j.ccl.2021.06.010_bib54","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud\u2019s phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.semarthrit.2018.03.019","article-title":"Practical suggestions on intravenous iloprost in Raynaud\u2019s phenomenon and digital ulcer secondary to systemic sclerosis: systematic literature review and expert consensus","volume":"48","author":"Ingegnoli","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhsa.2020.07.009","article-title":"Botulinum toxin for the treatment of intractable Raynaud phenomenon","volume":"46","author":"Gallegos","year":"2021","journal-title":"J\u00a0Hand Surg"},{"issue":"7","key":"10.1016\/j.ccl.2021.06.010_bib58","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2340\/00015555-2665","article-title":"Efficacy of botulinum toxin B injection for Raynaud\u2019s phenomenon and digital ulcers in patients with systemic sclerosis","volume":"97","author":"Motegi","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib59","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2018.01.043","article-title":"A\u00a0systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud\u2019s phenomenon","volume":"78","author":"Curtiss","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2017.08.018","article-title":"Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: a randomized, double-blind, controlled pilot study","volume":"78","author":"Wortsman","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0363-5023(80)80104-3","article-title":"Digital artery sympathectomy","volume":"5","author":"Flatt","year":"1980","journal-title":"J\u00a0Hand Surg"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jvs.2011.01.069","article-title":"Thoracic sympathectomy for digital ischemia: a summary of evidence","volume":"54","author":"Coveliers","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.ccl.2021.06.010_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/23320885.2018.1525684","article-title":"Hyperbaric oxygen therapy for digital ulcers due to Raynaud\u2019s disease","volume":"5","author":"Sato","year":"2018","journal-title":"Case Rep Plast Surg Hand Surg"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/000331970505600409","article-title":"Use of intermittent pneumatic compression for treatment of upper extremity vascular ulcers","volume":"56","author":"Pfizenmaier","year":"2005","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1358863X11398519","article-title":"Acrocyanosis: the flying dutchman","volume":"16","author":"Kurklinsky","year":"2011","journal-title":"Vasc Med Lond Engl"},{"issue":"6 Suppl","key":"10.1016\/j.ccl.2021.06.010_bib66","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1067\/mjd.2001.103266","article-title":"Chronic idiopathic acrocyanosis","volume":"45","author":"Nousari","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ccl.2021.06.010_bib67","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaad.2004.11.051","article-title":"Livedo reticularis: an update","volume":"52","author":"Gibbs","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1440-0960.2011.00819.x","article-title":"Reticulate eruptions: part 2. Historical perspectives, morphology, terminology and classification","volume":"52","author":"Parsi","year":"2011","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.ccl.2021.06.010_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ccl.2021.06.010_bib70","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/000331978703801007","article-title":"Cholesterol crystal embolization: a review of 221 cases in the English literature","volume":"38","author":"Fine","year":"1987","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2133.2001.04348.x","article-title":"Diagnostic impact and sensitivity of skin biopsies in Sneddon\u2019s syndrome. A report of 15 cases","volume":"145","author":"Wohlrab","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ccl.2021.06.010_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011","volume":"89","author":"Cappel","year":"2014","journal-title":"Mayo Clin Proc"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:54:10Z","timestamp":1760007250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865121000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0733865121000606"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2021.06.010","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raynaud Phenomenon and Other Vasospastic Disorders","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}